184 related articles for article (PubMed ID: 8163339)
1. Characterization of alpha 2-adrenoceptor binding sites in rabbit ciliary body membranes.
Jin Y; Verstappen A; Yorio T
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2500-8. PubMed ID: 8163339
[TBL] [Abstract][Full Text] [Related]
2. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
3. Nonadrenergic imidazoline binding sites on human platelets.
Piletz JE; Sletten K
J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
[TBL] [Abstract][Full Text] [Related]
5. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit.
Chidlow G; De Santis LM; Sharif NA; Osborne NN
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2238-45. PubMed ID: 7558717
[TBL] [Abstract][Full Text] [Related]
8. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium.
Bockman CS; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 1993 Dec; 267(3):1126-33. PubMed ID: 7903385
[TBL] [Abstract][Full Text] [Related]
9. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
11. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
Evans RG; Haynes JM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 and F2 alpha binding sites in the bovine iris ciliary body.
Csukas S; Bhattacherjee P; Rhodes L; Paterson CA
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2237-45. PubMed ID: 8389343
[TBL] [Abstract][Full Text] [Related]
13. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
Ordway GA; Jaconetta SM; Halaris AE
J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286
[TBL] [Abstract][Full Text] [Related]
14. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
Legrand C; Mhaouty S; Rigolot C; Maltier JP
J Pharmacol Exp Ther; 1993 Jul; 266(1):439-49. PubMed ID: 8101224
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
Mohuczy-Dominiak D; Garg LC
J Pharmacol Exp Ther; 1993 Jul; 266(1):279-87. PubMed ID: 8392554
[TBL] [Abstract][Full Text] [Related]
17. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
Fagerholm V; Philipp M; Hein L; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of alpha 2-adrenoceptors in human and rat myometrium and differential expression during pregnancy.
Bouet-Alard R; Mhaouty-Kodja S; Limon-Boulez I; Coudouel N; Maltier JP; Legrand C
Br J Pharmacol; 1997 Dec; 122(8):1732-8. PubMed ID: 9422821
[TBL] [Abstract][Full Text] [Related]
19. Characterization of [(3)H]idazoxan binding sites on human platelets.
Ruiz J; Barinagarrementeria G; Martín-Gómez JI; Callado LF; Meana JJ
Platelets; 2002 Jun; 13(4):241-6. PubMed ID: 12189026
[TBL] [Abstract][Full Text] [Related]
20. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
